Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 212686

In scope icon M 3 B
QID 212686 (Type "212686" in App Search)
A 38-year-old man comes to the clinic for “numbness and tingling” of his hands for the past 2 months. He immigrated from India 6 months ago and did not have health insurance until now. The patient reports a persistent rash that appeared 4 months ago that he attributes to the change in weather in Detroit compared to India. He denies weight loss, fever, chills, chest pain, vision changes, lightheadedness, or weakness. His past medical history is significant for poorly managed diabetes due to lack of health insurance. A physical examination demonstrates patches throughout the skin (Figure A), paresthesia of the distal hands bilaterally, and skin swelling on the left earlobe. What is the most appropriate treatment for this patient?
  • A

Dapsone, rifampin, and clofazimine

58%

74/127

Hydroxychloroquine

9%

12/127

Insulin

4%

5/127

Rifampin, isoniazid, pyrazinamide, ethambutol

8%

10/127

Terbinafine

9%

12/127

  • A

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

This patient has the classic presentation of leprosy (e.g., paresthesia of distal extremities, hairless skin lesions, and skin thickening at the earlobe), which is due to infection with Mycobacterium leprae.

M. leprae is an acid-fast mycobacterium that thrives in cool temperatures. It is endemic in developing areas such as India, Nepal, regions of Africa, and South America. It is worth noting that in the United States, armadillos are the main reservoir. Patients with a high degree of cell-mediated immunity and delayed hypersensitivity present with tuberculoid disease which manifests as well-demarcated skin lesions. Patients with a weak immune response present with a lepromatous response which manifests as a symmetric glove and stocking neuropathy, red skin patches with/without sensory changes, and profound facial deformities (e.g., Leonine facies) secondary to skin thickening, nodular earlobes, and loss of eyebrows/eyelashes. Treatment of tuberculoid disease involves dapsone or rifampin. However, in this patient presenting with lepromatous disease, dapsone, rifampin, and clofazimine are indicated.

Figure A is a clinical image of a lepromatous lesion.

Incorrect Answers:
Answer 2: Hydroxychloroquine is one of the main treatment options for systemic lupus erythematosus, which can also present with skin rash and sensory changes. However, this patient’s skin rashes are more characteristic of leprosy.

Answer 3: Insulin is one of the treatments of diabetes, which, in severe cases, can present with sensory changes secondary to nerve damage. Although this patient has uncontrolled diabetes, it does not explain the characteristic skin lesions and nodular earlobe.

Answer 4: Rifampin, isoniazid, pyrazinamide, ethambutol is the standard treatment for active tuberculosis (TB), which often presents with pulmonary symptoms and fever. This patient is not exhibiting signs of TB.

Answer 5: Terbinafine is one of the treatments for tinea corporis, a fungal infection of the skin. Although the skin lesion can look similar to that of leprosy, tinea corporis does not explain the paresthesia or nodular earlobe seen in this patient.

Bullet Summary:
Leprosy can present with symmetrical paresthesias, skin lesions, and facial deformities; the treatment of choice for lepromatous leprosy is dapsone, rifampin, and clofazimine.




Authors
Rating
Please Rate Question Quality

2.8

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(5)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options